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Abstract: 
The researchers studied the effectiveness of a nursing intervention in promoting adjustment and 
symptom management in individuals with multiple sclerosis (MS). This was a 4-year 
longitudinal study to determine whether the 4-week intensive outpatient program was effective in 
increasing adjustment to MS and if the treatment effect would last over time. A sample of27 
individuals with MS participated in the study. Treatment participants had significant 
improvements in symptom management at the 4-yearfollow up. This improvement was attribut-
able to significant improvements in sleep and fatigue levels. Although adjustment and self-
efficacy scores improved in the treatment group over time, this improvement was not superior to 
the control group. This was anticipated because the behavioral changes would precede 
improvement in adjustment to life following the diagnosis of MS. 
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Article: 
This study tested a comprehensive nursing intervention designed to help individuals with 
multiple sclerosis (MS) gain better control of their symptoms and improve their adjustment to 
this progressive disease. The intervention was designed be provided by advanced practice nurses 
to supplement or augment medical management that these patients receive from their primary 
care providers. 
 
DIFFICULTIES IN STUDYING ADJUSTMENT TO MS 
MS is one of the most common causes of neurological disability in young adults. About 1 
million adults are affected with MS worldwide (Williams, Rigby, Airey, Robinson, & Ford, 
1995), making MS a significant health care problem. MS attacks white matter in the central 
nervous system, resulting in physical, sensory, affective, and cognitive difficulties (Devins et al., 
1993), and it is characterized by uncertainty and a progressively disabling course (Stuifbergen, 
Seraphine, & Roberts, 2000). The severity of physical, emotional, and cognitive functioning 
varies widely between individuals and within individual MS patients over the course of the 
disease (Beatty, 1993). 
 
PSYCHOSOCIAL ADJUSTMENT 
MS often leads to changes in emotion and cognitive ability, to fatigue, and to pain that may 
challenge the ability of patients to adjust to their disabilities. As a chronic illness, MS requires 
varying patterns of personal and familial social adjustment. In a study comparing quality of life 
(QOL) in 207 individuals who had either MS, inflammatory bowel disease, or rheumatoid 
arthritis, Rudick, Miller, Clough, Gragg, and Farmer (1992) reported the worst QOL in the 
participants with MS. All participants had been diagnosed for more than 10 years, yet duration of 
MS was not related to QOL scores. 
 
The degree of disability is a key variable in studying adjustment to MS. Viney (1986) reported 
that adjustment to the reality of disability allowed individuals to achieve personal integrity 
focused on skills, problem solving, and mastery over the degree of disability. Wassem (1992) 
noted that 51% of the variance in adjustment to MS was predicted by the degree of disability in 
combination with self-efficacy and outcome expectations. 
 
THEORETICAL FRAMEWORK 
The theoretical framework for this study was Bandura’s (1982) social cognitive theory, with an 
emphasis on the construct of self-efficacy. Self-efficacy was Bandura’s (1989) term for an 
individual’s confidence in being able to perform a given behavior. As self-efficacy increases, the 
likelihood of an individual’s successful performance of a specific behavior increases, as does the 
amount of effort and persistence in performing that behavior in the face of obstacles (Bandura, 
1982). 
 
For nurses working with clients who have MS, this increased effort and persistence are essential 
in teaching the behavioral changes necessary for better adjustment to this long-term, progressive 
disease. 
 
Many chronic, physically disabling conditions have been investigated in relation to self-efficacy 
expectations and rehabilitation, with higher self-efficacy levels being predictive of success: 
coronary artery disease, pain tolerance, asthma, bulimia, and hypertension. Increased self-
efficacy has been linked with adherence to exercise with chronic obstructive pulmonary disease, 
increased activity following cardiac rehabilitation, the behavioral treatment of arthritis, and an 
increased ability to tolerate pain. 
 
Following the diagnosis of a chronic illness, patients often experience decreased well-being, 
decreases in activities, and symptom amplifications that negatively affect overall adjustment. 
Introducing the intervention to teach about the disease, symptom management, and self-care 
behaviors, including stress reduction measures, will increase the use of self-care behaviors, 
leading to improved well-being, increased activities, and better symptom management. This will 
bring about better physical, psychological, and social adjustment (see Figure 1). We tested the 
intervention with outcome variables of adjustment and symptom management. 
 
In summary, MS is a chronic, progressively disabling neurological disease with no known cure 
that can cause physical, sensory, affective, and cognitive symptoms. These difficulties challenge 
the ability of patients to adjust to their disabilities and require varying patterns of personal and 
familial psychosocial adjustment. Bandura’s (1982) social cognitive theory with the construct of 
self-efficacy has provided a useful framework for adjustment studies with other chronic illnesses 
and 
 
was used in this study to test an intervention for promoting symptom management and 
adjustment to MS. 
 
PURPOSE OF THE STUDY 
The purpose of this study was to test the hypotheses that participants in the intervention group, 
compared to those in the control group, would have improved (a) symptom management (pain, 
fatigue, sleep), (b) self-efficacy for adjustment behaviors, and (c) adjustment at posttest 
measures. Because this was an exploratory study, these hypotheses were tested at the p < .10 
level of significance. 
 
DESIGN 
The study used a randomized, two-group (treatment and control) experimental, longitudinal 
study design. Because of the chronic nature of MS, we measured both short-term and long-term 
effects of the treatment. The expected short-term improvements would mean little if the 
participants did not make the behavioral changes necessary to create long-term benefits in 
improved symptom management and adjustment. 
 
SAMPLE 
The target population for this study consisted of individuals with MS. It is preferable that the 
intervention be delivered within the early years following diagnosis to cut down on the initial 
rough years of trial and error attempts to manage patients’ symptoms. Twenty-seven participants 
were recruited for the study. Study participants were fairly representative of the population on 
the parameters of age (range 18 to 54 years, M = 44 years), number of years with MS (range 0.5 
to 7, M = 3.49), disability levels (range 0 to 9, M = 3.36, where 0 represents no disability and 9 
being confined to bed), and gender (72% female, which is slightly higher than the incidence of 
MS for the female gender [66%]). Treatment and control participants did not differ significantly 
on pretest measures of age, degree of disability, number of years with MS, or adjustment. 
 
Sample attrition was a problem because 5 participants died or were lost to follow-up during the 
course of the study, and 6 were lost after being assigned to the control group. We conducted an 
attrition analysis comparing those who dropped out of the study with those who continued. The 
dropouts did not significantly differ from those who continued with the study on key variables of 
adjustment, self-efficacy, and symptom distress. However, the dropouts (M =17.2) had more 
symptom distress (range 0 to 30) at a clinical level than those who continued (M = 12.5). The 
attrition rates for the treatment (22%) and control (23%) groups did not differ after deleting those 




Following human participants approval, potential participants were recruited from attendees at an 
MS workshop and physician clients and through an advertisement in the newsletter of the state 
chapter of the National Multiple Sclerosis Society (NMSS). Letters were sent to all potential 
participants, and informed consent was obtained from those individuals who agreed to participate 
in the study. Participants were randomly assigned to either the treatment or the control group 
following receipt of informed consent. Participants selected for the treatment group were 
contacted by phone to assign them to either the Tuesday or Thursday treatment session. Both 
treatment and control participants were sent an introductory letter explaining their group 
assignment with their first questionnaires. 
 
The nursing intervention (MS-REHAB) used the four forms of behavior acquisition proposed by 
Bandura (1989) in his social cognitive theory: verbal persuasion, role modeling, performance 
accomplishment, and vicarious experience). Details of the MS-REHAB program that was tested 
in this study are presented in Table 1. The intervention was designed as a group program so that 
participants could use others in the group as positive role models. The discussions (verbal 
persuasion) were designed to expose participants to methods for modifying their responses to 
MS. Participants were given homework assignments to use these learned behaviors in everyday 
life (performance accomplishment), with a discussion of their successes in the group sessions the 
following week. The successes of the other group members (vicarious experience) encouraged 
other individuals to attempt the adjustment behaviors. 
 
The MS-REHAB program consisted of four 2-hour sessions with treatment group participants 
meeting once a week over 4 consecutive weeks. Program content was developed from the 
literature and 25 years of experience working with individuals with MS. During the first session, 
participants discussed the disease process of MS, factors that influence MS, pain control, and the 
need to manage stress in one’s life. Participants were also taught how to do progressive muscle 
relaxation. After using their newly learned progressive muscle relaxation daily and keeping 3-
day diet diaries, participants discussed the dietary concerns of MS, the pacing of activities, 
energy conservation techniques, and how best to communicate with their health care providers in 
the second session. They also learned how to do guided visual imagery, which they were 
instructed to use daily for the intervening week. At the third session, psychosocial issues, 
including role changes, the importance of a support network, MS care and management decision 
making, and employment were discussed. At the fourth session, participants covered memory 




questionnaires in a timely manner. Table 1 outlines the treatment sessions’ content and 
homework. 
 
The treatment sessions were offered in the evenings from 7 p.m. until 9 p.m. over 4 consecutive 
weeks at the College of Nursing. Participants discussed issues related to controlling MS, were 
taught adjustment behaviors, and were given homework assignments, as described in the MS-
REHAB program. They practiced the behaviors learned in the previous class and then reported 
on their successes at the following meeting. 
 
Both treatment and control participants completed the study instruments at the time of 
enrollment, 3 months after the intervention was completed, and every 6 months over a 4-year 
period after enrollment in the study. All instrument packets were assigned participant numbers to 
assure confidentiality. The master sheet matching participants with numbers was kept in a locked 
office accessible only to the research team. The assignment of participant numbers was also 
necessary because of the repeated-measures design of the study so that scores were accurately 
assigned to the appropriate participants over time. 
 
INSTRUMENTS 
The Self-Efficacy for Adjustment Behaviors (SEAB) Scale consists of 26 adjustment behaviors 
with a 4-point, Likert-type response pattern. Each item ranges from 0 (no confidence in being 
able to perform the behavior) to 4 (total confidence in being able to perform the behavior), 
giving a range of potential scores of 0 to 104. The SEAB was developed to be used as a mailed, 
self-report checklist. A sample of 256 individuals with MS completed the SEAB in the 
instrument development study (Wassem, 1992) with the original 29 items on a scale ranging 
from 1 to 5 (M = 112, range 65 to 145, SD = 17.23). Cronbach’s alpha coefficient of internal 
consistency reliability was .91. Correlations of SEAB scores with single self-report visual ana-
logue adjustment items were significant at a moderate level: social (r=.40), psychological 
(r=.39), and physical adjustment (r = .43) (Wassem, 1987). The test-retest level at 4 weeks for 
control participants in a larger study was r = .827 (Wassem, 1992). Cronbach’s alpha statistic for 
internal consistency reliability for the SEAB with the present study was .87. 
 
Adjustment was measured using both the Psychosocial Adjustment to Illness Scale–Self-Report 
(PAIS-SR) (Derogatis, 1986) and total adjustment scores calculated from visual analogue scales. 
The PAIS-SR has been shown to be a valid, reliable, and objective measure of adjustment to 
illness. The PAIS- SR has been used in the measurement of psychosocial adjustment in 
respondents with chronic illnesses or injuries, such as Hodgkin’s disease, cancer, renal dialysis, 
burns, hypertension, and cardiac disease. Although the 45-item instrument consists of seven 
subscales, those pertaining to sexual relationships and extended family relationships were not 
used in this study because they have low reliability levels and have been frequent sources of 
missing data in prior research. Subscales included in the study were Health Care Orientation, 
Vocational Environment, Domestic Environment, Social Environment, and Psychological 
Distress. This dropped the number of items used to 34, with a range of possible scores of 1 to 
136. Because of the small sample size of the current pilot study, the PAIS-SR was used as a total 
score. Cronbach’s alpha statistic for internal consistency reliability for the PAIS-SR with the 
current sample was .91. 
 
In addition to the PAIS-SR, self-report visual analogue adjustment items of psychological, 
social, and physical adjustment were used to measure adjustment. These three items were 
summed to give an overall total adjustment scale with a range of 0 to 30. The total adjustment 
scale was used as another measure of the primary outcome variable of adjustment to supplement 
information from the PAIS-SR. 
 
The Modified Disability Status Scale has been used as an objective and reproducible method of 
assessing the degree of disability in individuals with MS. Modification of Kurtzke’s (1955) tool, 
the Disability Status Scale, was made because only the second part of the instrument, which 
ranks disability levels from 0 (no disability) to 9 (complete bed rest), was used. The participants 
were asked to circle the item that best represented their current level of functioning. Because this 
is a self-report physical ability level, reliability measures, including test-retest reliability, are not 
appropriate because patients’ conditions may change between measurements. 
 
We collected data on the participants’ self-reported symptom severity scores (pain, fatigue, 
sleep) and adjustment scores (psychological, social, and physical) using visual analogue scales 
ranging from 0 to 10. The symptom severity scales of pain, fatigue, and sleep were summed to 
give an overall symptom severity scale with a range of possible scores of 0 to 30. Although there 
are lengthy and elaborate instruments for measuring these symptoms, we used the visual 
analogue scales because they give reliable information without placing an undue burden of time 
on the participants to complete the questionnaires at each data measurement point. 
 
Items on the personal inventory were selected for relevance to the study, significance from the 
review of literature, and selection rating by a panel of experts. The personal inventory was 
designed by the investigators to gather demographic data, including age, gender, age at 
diagnosis, number of years with MS, and length of disability. 
 
DATA ANALYSIS 
The data were entered into a computer on receiving the completed instrument packets. The 
researchers used the SPSS (Version 10.1) (SPSS Inc., 2000) and SAS (SAS Institute, 1999) 
software packages for data analysis and hypothesis testing. 
 
Because this was an exploratory test, all hypotheses were tested at the p < . 10 level of 
significance. Analysis of the change in means over time for all outcome variables was conducted 
with the SAS mixed-model procedure PROC MIXED. This analysis-of-covariance approach 
employs an iterative maximum likelihood estimation approach, which allows for the analysis of 
repeated measures of all cases, even when some data are missing (Kleinbaum, Kupper, Muller, & 
Nizam, 1998; Littell, Milliken, Stroup, & Wolfinger, 1996). 
 
FINDINGS 
Because of the strong impact of age at diagnosis and illness severity on key outcome measures, 
these variables were added into the analysis as covariates for each hypothesis. The analytical 
approach used was a repeated-measures MANCOVA, with age at diagnosis and illness severity 
as covariates in the analysis. Data were analyzed at 10 time points from baseline to the 4-year 
follow-up. 
 
Hypothesis 1 proposed that symptom management would be improved in the treatment group. 
Fatigue symptom management improved for the treatment group at all posttest measures 
compared to the pretest scores. The fatigue levels of the treatment participants were lower than 
those of the control participants at most data collection points, as indicated by a group-by-time 
interaction (F=1.74, p =.09). Sleep disturbance scores for the treatment group were significantly 
better than for the control group at the 4-year follow-up, as indicated by a group-by-time 
interaction (F = 1.85, p = .07). Pain levels increased at all posttest data collection points. 
Symptom severity scores were computed by adding together the three symptom severity scores 
(possible range 0 to 30). The impact of improved sleep and decreased fatigue contributed to the 
significant findings for improved symptom severity scores at the 4- year follow-up, as indicated 
by a group-by-time interaction (F = 2.15, p = 0.03; see Figure 2). 
 
Hypothesis 2 proposed that self-efficacy, as measured by SEAB scores, would increase 
following the intervention, with higher SEAB scores for the treatment participants on posttest 
measures than for control participants. Although the inspec- 
 
tion of mean SEAB scores at each data collection point revealed increases for the treatment 
participants on most posttreatment measures, the pattern of scores over time was not different 
from that of the control group, as indicated by the nonsignificant group-by-time interaction (F = 
0.89, p = .55). Hypothesis 2 was not supported. 
 
Hypothesis 3 proposed that adjustment, as measured by PAIS-SR scores, for the treatment 
participants would be higher than for the control participants on posttreatment measures. 
Although the inspection of mean PAIS-SR scores at each data collection point revealed increases 
for the treatment participants on most post treatment measures, the pattern of scores over time 
was not different from that of the control group, as indicated by the nonsignificant group-by-time 
interaction. The three-item adjustment scale (psychological, social, and physical) functioned 
better than the PAIS-SR with this sample. The treatment group improved at all but one data 
collection point using this three-item adjustment measure, but the group-bytime interaction at the 
4-year follow-up was not significant (F = 0.69, p = .72). Hypothesis 3 was not supported. 
 
DISCUSSION 
Because there is no cure for or effective treatment of MS, behavioral adaptation to the disease 
(such as symptom management and adjustment) is key to maintaining QOL with MS. This study 
demonstrated decreases in fatigue and improved sleep among the treatment participants. The 
management of pain was not improved by the intervention. This finding is consistent with 
Nurmikko’s (2000) report that despite the prevalence of MS pain, few patients find relief from 
this symptom. Stenager, Knudsen, and Jensen (1995) found that there were significant increases 
in the number of acute and chronic pain syndromes, including tension and pain in the 
extremities, spasms, lower back pain, Lhermitte’s sign, and neuralgia over the 5-year course of 
their study with MS patients. It may be that more aggressive medical management is needed to 
supplement the intervention for better control of patients’ pain. 
 
In contrast to the treatment effect on symptom management, the more global scales of self-
efficacy and adjustment were not significantly improved by the treatment. Adjustment to a 
chronic, incurable illness such as MS is very complex. Self- efficacy scores were moderately 
high for all participants. Although there was a treatment effect on self-efficacy scores at 6 
months, scores varied between moderate scores of 60 to 70 for the remainder of the data 
collection points. Both treatment and control participants had moderate levels of confidence in 
performing the adjustment behaviors. Within the social cognitive theory, Bandura (1982) 
proposed that individuals must believe not only that they can do a behavior (self-efficacy) but 
also that the behavior will make a difference in the outcome of their illness, and they must use 
the behavior consistently over time. It may be that even though they believe that they can do a 
given behavior, patients are unable or unwilling to make the behavior changes that would 
improve their symptom management. The small sample size precluded testing ideas about the 
interplay among these variables. 
 
The increases in PAIS-SR scores for the treatment group were encouraging. The control group, 
however, also reported increased PAIS-SR scores. This may be an effect of being tested or 
seeing the list of adjustment behaviors every 6 months, cueing them to try these behaviors in an 
attempt to manage their MS. The self-report single adjustment items were better predictors of 
change than the PAIS-SR scores with this group of participants. It may be that the PAIS-SR does 
not measure adjustment to MS as well as it measures adjustment to other chronic illnesses. 
 
LIMITATIONS 
The sample size was small, and there was attrition over the 4 years reported in this article, but a 
strength was that participants were followed for 4 years. The sample included members of a state 
chapter of the NMSS, who may be representative of those individuals with MS who are not 
members of the NMSS. Although assignment to treatment and control groups was random and 
occurred after consent was obtained, participants obviously knew of their assignment to the 
treatment or control group, and this may have influenced their responses. 
 
A methodological problem and potentially useful finding was that many of the control 
participants wrote on their questionnaires that they liked receiving their questionnaires because 
completing the SEAB reminded them to do the “right things” to manage their MS. This effect in 
combination with a possibly strong Hawthorne effect negatively skewed the results and may 
have given many of the control participants a weaker form of the intervention. 
 
Future research will include an intensive maintenance program to cue participants to make the 
behavior changes necessary to manage their MS, and control participants will not complete the 
self-efficacy measure to prevent pretest sensitization and dilution of the treatment. Additionally, 
nurse practitioners will be added to prescribe an optimal uniform medicine protocol to augment 
the nursing intervention with the hope of a more standardized design and increased symptom 
control. 
 
APPLICATION OF RESEARCH TO PRACTICE 
It is clear that many aspects of successful living with MS fall well outside the traditional medical 
model. Nursing interventions that focus on improving symptom management through the use of 
adjustment behaviors, however, may have an impact on the well-being of patients with MS. We 
have included the content of our intervention in Table 1 so that practitioners can teach these 
behaviors to their MS patients. With decreased length of stay in the hospital and higher patient-
to-nurse ratios, patient teaching is one area that often suffers. This research project presented an 
outpatient evening program for promoting adjustment to MS that was conducted by a nurse. 
Participants enjoyed the classes and learned how to manage their illness. This type of program 




Bandura, A. (1982). Self-efficacy mechanism in human agency. AmericanPsychologist, 37, 122-
147. 
Bandura, A. (1989). Human agency in social cognitive theory. American Psychologist, 44, 
1175-1184. 
Beatty, W. W. (1993). Cognitive and emotional disturbances in multiple sclerosis. Neurological 
Clinics, 11, 189-204. 
Derogatis, L. R. (1986). The Psychosocial Adjustment to Illness Scale (PAIS). Journal of 
Psychosomatic Research, 30, 77-91. 
Devins, G. M., Edworthy, S. M., Seland, T. P., Klein, G. M., Paul, L. C., & Mandin, H. (1993). 
Stability and determinants of psychosocial well-being in multiple sclerosis. Rehabilitation 
Psychology, 38, 11-25. 
Kleinbaum, D. G., Kupper, L. L., Muller, K. E., & Nizam, A. (1998). Applied 
regression analysis and multivariable methods. New York: Duxbury. Kurtzke, J. F. (1955). A 
new scale for evaluating disability in multiple sclerosis. 
Neurology, 5, 580-583. 
Littell, R. C., Milliken, G. A., Stroup, W. W., & Wolfinger, R. D. (1996). SAS systems for mixed 
models. Cary, NC: SAS Institute. 
Nurmikko, T. J. (2000). Mechanisms of central pain. Clinical Journal of Pain, 16(Suppl. 2), 
S21-S25. 
Rudick, R., Miller, D., Clough, J., Gragg, L., & Farmer, R. (1992). Quality of life in multiple 
sclerosis: Comparison with inflammatory bowel disease and rheumatoid arthritis. Archives of 
Neurology, 49, 1237-1242. 
SAS Institute. (2001). SAS version 8.2. Cary, NC: Author. 
SPSS Inc. (2000). SPSS version 10. Chicago, IL: Author. 
Stenager, E., Knudsen, L., & Jensen, K. (1995). Acute and chronic pain syndromes in multiple 
sclerosis: A 5-year follow-up study. Italian Journal of Neurologic Science, 16, 629-32. 
Stuifbergen, A. K., Seraphine, A., & Roberts, G. (2000). An explanatory model of health-
promotion and quality of life in chronic disabling conditions. Nursing Research, 49, 122-129. 
Viney, L. L. (1986). Expression of positive emotion by people who are physically ill: Is it 
evidence of defending or coping? Journal ofPsychosomatic Research, 30(1), 27-34. 
Wassem, R. A. (1992). Self-efficacy as a predictor of adjustment to multiple sclerosis. Journal 
of Neuroscience Nursing, 24, 224-229. 
Williams, R., Rigby, A., Airey, M., Robinson, M., & Ford, H. (1995) Multiple sclerosis: Its 
epidemiological, genetic and health care impact. JournalEpidemiology and Community 
Health, 49, 563-569. 
